- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Betta Pharmaceuticals Co Ltd (300558)
Assess today's live Betta Pharmaceuticals Co Ltd (300558) share price, performance and insights using our live Shenzhen: 300558 stock exchange data.
Analyse the historical data and Betta Pharmaceuticals Co Ltd share price performance charts on this page. Our technical summary section provides analysis on Betta Pharma share price buy/sell indicators using real-time data (or discuss the Betta Pharma (300558) stock price today with other investors in the Betta Pharma SZ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SZ 300558 share price (ISIN: CNE100002DD9) to enhance your trading decisions with our free investment tools and resources.
What Is the Betta Pharmaceuticals Co Ltd Share Price Today?
The Betta Pharma share price today is 51.23.
What Is the Stock Symbol for Betta Pharmaceuticals Co Ltd
The stock symbol (or 'ticker') for Betta Pharmaceuticals Co Ltd is "300558."
What Stock Exchange Does Betta Pharmaceuticals Co Ltd Trade On?
Betta Pharmaceuticals Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Betta Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Betta Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Betta Pharmaceuticals Co Ltd share price performance charts on this page. Our technical summary section provides analysis on Betta Pharma share price buy/sell indicators using real-time data (or discuss the Betta Pharma (300558) stock price today with other investors in the Betta Pharma SZ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SZ 300558 share price (ISIN: CNE100002DD9) to enhance your trading decisions with our free investment tools and resources.
What Is the Betta Pharmaceuticals Co Ltd Share Price Today?
The Betta Pharma share price today is 51.23.
What Is the Stock Symbol for Betta Pharmaceuticals Co Ltd
The stock symbol (or 'ticker') for Betta Pharmaceuticals Co Ltd is "300558."
What Stock Exchange Does Betta Pharmaceuticals Co Ltd Trade On?
Betta Pharmaceuticals Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Betta Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Betta Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Shenzhen
Currency in CNY
51.23
-1.67(-3.16%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.86
52.85
52 wk Range
40.10
79.80
300558 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.8652.85
52 wk Range
40.1079.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300558 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
43.06
Downside
-15.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 43.06
(-15.95% Downside)
Earnings
Latest Release
23/04/2026
EPS / Forecast
0.56 / --
Revenue / Forecast
1.04B / --
Compare 300558 to Peers and Sector
Metrics to compare | 300558 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300558PeersSector | |
|---|---|---|---|---|
P/E Ratio | 50.5x | 42.1x | −0.5x | |
PEG Ratio | 5.99 | 0.63 | 0.00 | |
Price/Book | 3.3x | 2.4x | 2.6x | |
Price / LTM Sales | 6.0x | 3.2x | 3.2x | |
Upside (Analyst Target) | −18.7% | 41.9% | 49.5% | |
Fair Value Upside | Unlock | 9.2% | 7.1% | Unlock |
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China and internationally. The company offers Icotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat first-line treatment of locally advanced or non-small-cell lung cancer (NSCLC); Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of NSCLC; and Bevacizumab, an antibody drug against human vascular endothelial growth factor that is used to treat NSCLC, colorectal cancer, and other solid tumor indications. It also develops BPI-D0316, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) targeting T790M mutation; EYP-1901, an investigational long-acting treatment for wet AMD, non-proliferative diabetic retinopathy, diabetic macular edema, and pmCNV; and MCLA-129, a bispecific antibody targeting both EGFR and c-Met. In addition, the company develops BPI-371153 for the treatment of patients with locally advanced or metastatic solid tumor or relapsed/refractory lymphoma; CFT8919, an in vitro and in vivo model of EGFR L858R-driven NSCLC; and Balstilimab, a human monoclonal antibody targeting programmed cell death protein 1 and an immune checkpoint inhibitor. Further, it develops a recombinant human serum albumin injection under the OsrHSA name; and products for the treatment of solid tumor under the BPI-452080, MRX2843, BPI-460372, BPI-221351, BPI-520105, BPI-572270, and BPI-585725 names. The company was founded in 2003 and is headquartered in Hangzhou, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Betta Pharma (Shenzhen: 300558) Share Price Today?
The Betta Pharma stock price today is 51.23 CNY.
What Stock Exchange Does Betta Pharma (300558) Trade On?
Betta Pharma is listed and trades on the Shenzhen Stock Exchange.
What Is the Ticker (Stock Symbol) for Betta Pharma?
The stock symbol (also called a 'ticker') for Betta Pharma is "300558."
Does Betta Pharma Pay Dividends? What’s The Current 300558 Dividend Yield?
Yes, 300558 Pays Dividends to its Shareholders. The current Betta Pharma dividend yield is 0.39%.
What Is the Current Betta Pharma Market Capitalisation?
As of today, Betta Pharma (Shenzhen: 300558) market cap is 21.55B CNY.
What Is Betta Pharma's (300558) Earnings Per Share (TTM)?
The Betta Pharma EPS is currently 1.05 (Trailing Twelve Months).
When Is the Next Betta Pharma Earnings Date?
Betta Pharma's next earnings report will be released on 24/04/2026.
Is 300558 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Betta Pharma moving averages and other technical indicators, the daily buy/sell signal for 300558 stock is Strong Buy.
How Many Times Has Betta Pharma Stock Split?
Betta Pharma has split 0 times. (See the 300558 stock split history page for full effective split date and price information.)
How Many Employees Does Betta Pharma Have?
Betta Pharma has 1785 employees, based on their latest Companies House report.
What is the current trading status of Betta Pharma (Shenzhen: 300558)?
As of 13/05/2026, Betta Pharma (300558) is trading at a share price of 51.23 CNY, with a previous close of 52.90 CNY. The stock has fluctuated within a day range of 50.86 CNY to 52.85 CNY, while its 52-week range spans from 40.10 CNY to 79.80 CNY.
What Is Betta Pharma (300558) Price Target According to Analysts?
The average 12-month price target for Betta Pharma is 43.06 CNY, with a high estimate of 43.06 CNY and a low estimate of 43.06 CNY. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -15.95% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.